4//SEC Filing
GANNON STEVEN 4
Accession 0001209191-22-039827
CIK 0001582313other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 5:26 PM ET
Size
5.4 KB
Accession
0001209191-22-039827
Insider Transaction Report
Form 4
GANNON STEVEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 totalExercise: $30.11Exp: 2032-06-27→ Common Shares (18,000 underlying)
Footnotes (1)
- [F1]100% of the common shares subject to the option will vest on the earlier of (i) the first anniversary of grant date and (ii) the day immediately preceding the day of the Issuer's next annual general meeting of shareholders.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001643085
Filing Metadata
- Form type
- 4
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 5:26 PM ET
- Size
- 5.4 KB